trial

Schizophrenia TreAtment With electRic Transcranial Stimulation

NCTId NCT02535676
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 100 (actual)
Sponsored by University of Sao Paulo
Primary completion 2018-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
100 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2014-11
Primary completion
2018-05
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
transcranial direct current stimulation

Sponsors

University of Sao PauloLead Sponsor
Instituto Bairral de PsiquiatriaCollaborator
Stanley Medical Research InstituteCollaborator

Investigators

1
Leandro Valiengo, PhDPrincipal Investigator

Sites

1 total
São Paulo, Brazil

Linked catalysts

1
Schizophrenia TreAtment With electRic Transcranial Stimulation — primary completion2018-05

Facts & assertions

4 sourced
Enrollment
100
Phase
PHASE3
Primary Completion Date
2018-05
Status
COMPLETED
relationships
The graph out of here
drug
transcranial direct current stimulation
drug
lead_sponsor
University of Sao Paulo
company
collaborator
Instituto Bairral de Psiquiatria
company
Stanley Medical Research Institute
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Leandro Valiengo, PhD
person